EP0711113A1 - Procede de fabrication de corps plastiques bactericides/fongicides - Google Patents
Procede de fabrication de corps plastiques bactericides/fongicidesInfo
- Publication number
- EP0711113A1 EP0711113A1 EP95906894A EP95906894A EP0711113A1 EP 0711113 A1 EP0711113 A1 EP 0711113A1 EP 95906894 A EP95906894 A EP 95906894A EP 95906894 A EP95906894 A EP 95906894A EP 0711113 A1 EP0711113 A1 EP 0711113A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- coated
- plastic
- coating
- blank
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/10—Metal compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
- A01N59/20—Copper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/203—Solid polymers with solid and/or liquid additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Definitions
- the invention relates to processes for the production of plastic bodies which can be further processed, in particular for the production of objects for medical use, which have an antimicrobially active content of metals or metal compounds (hereinafter referred to as active ingredients).
- metals or their compounds whose oligodynamic effect is known, such as Silver, copper and gold, but also other heavy metals such as Zinc and also lanthanides, which act on bacteria and / or fungi in the sense desired according to the invention, i.e. kill them, prevent their multiplication or their adhesion to or implantation in the plastic or at least greatly reduce it.
- this relates to the costs of the amounts of metal or metal compounds, in particular silver, required for the intended purpose, if these substances are to be incorporated into the plastic in powder form, the lower limit of effectiveness always being the The order of magnitude of 1% by weight of the plastic is mentioned, but larger proportions are always stated as being even more effective.
- this relates to the costs for the ultimately rather complex - and accordingly expediently only to be used for selected cases - wet method of treating the plastics, e.g. according to DE-C-42 26 810, according to which very small amounts of the active ingredient are sufficient.
- Another way of avoiding the high material costs for the antimicrobial finishing of objects is not to provide the plastic as a whole with an antimicrobial, but to subsequently coat the objects made from this plastic with active substances.
- the object of the present invention is therefore to provide ⁇ provision of a method for the preparation of oligodynamically active plastic bodies which After the above ⁇ parts do not have, ie, are simple to produce, only require a small amount of the oligodynamic metal or its compound (s) and are equally effective on all, even inaccessible, surfaces.
- plastic bodies which contain one or more oligodynamically active metals or metal compounds as the active ingredient, which are characterized in that the active ingredient is embedded in the plastic in the form of discrete particles , wherein the amount of active ingredient is not more than 1.0% by weight, preferably not more than 0.5% by weight, based on the total weight of the plastic body, and the maximum of the discrete particle size of the active ingredient is below 500 nm lies.
- Well-handled active substances of all kinds in powder form are only produced and offered with finenesses down to the micron range (ie ⁇ 1 ⁇ m) and submicron range (ie> 0.1 ⁇ m).
- the specific surface area thus achieved is, for example, for the finest commercially available silver powder with a nominal grain size of 2 to 3.5 ⁇ m, which of course also has a certain proportion of coarser and sub-micron particles which is unavoidable due to the process has, according to the manufacturer, about 0.5 to 1 m 2 / g.
- Other, frequently used and also cheaper silver powders have coarser particles and accordingly lower specific surfaces.
- plastic bodies are therefore preferably produced in such a way that the blank is coated with the bactericidally and / or fungicidally (oligodynamically) active substance by means of a chemical or physical process, the coated blank (precursor) obtained is comminuted and / or melted, from which then the desired plastic body is produced by conventional methods.
- the layer thickness is preferably 1 to 50 nm.
- the maximum of the particle size distribution of the active ingredient in at least one dimension is preferably below 100 nm, more preferably 10 nm. In the case of thin layers, the particle size can also be smaller than 1 nm.
- Crystalline materials (PTFE, some polyimides) have to be crushed, for example, by grinding; Melting is included (practically) not applicable. They are then brought into the desired shape by, for example, (pressure) sintering.
- plastics with a low but finely dispersed content of metal particles (or particles from metal compounds) with a correspondingly large specific, active surface are equivalent in effect to plastics that have a much higher, but have less finely dispersed metals (or metal compounds) with a correspondingly smaller specific, active surface.
- plastics produced according to the above-mentioned process that these plastics are suitable for particularly critical applications by suitable process control in the production of the layer of metal (or of metal compounds) it can be equipped with particles whose size can be influenced from the outset for an optimal long-term effect.
- the coating can be done on foils (see example), which can then be shredded and further processed. However, it can also be applied to fibers or to granules, with the same result of producing the desired final concentration of the active ingredient in the plastic.
- plastic blanks Those in which fillers have already been mixed can also be used as plastic blanks. Preference is given to plastic blanks whose fillers do not significantly change the chemical or physiological properties of the plastic used as a preliminary product.
- Plastic blanks with fillers also have a larger surface area, which has a favorable effect on the coating according to the invention (better dispersion).
- plastics in the form of foils, tapes (a special case of foils), fibers or granules with one or more active substances in thin layers, preferably with layer thicknesses between 10 and 100 nm, is possible in a variety of ways with chemical and above all, possible with physical processes.
- the coating is only carried out with metals in the elementary state, and that the metal layer formed during the coating process is generally very dense and therefore in periods of time relevant for processing considerations, e.g. has a barrier effect for water vapor.
- thermoplastic polyurethane is a preferred plastic raw material Novel plastics similar to common polyurethanes (eg "carbothanes”) are also mentioned here.
- the aim of the process variants listed below is to bring the plastic, which has been coated with active ingredient, into a shape such that its further processing into intermediate products in mixers, kneaders, extruders or other machines or its final processing either in extruders, in Injection molding machines or in other facilities, such as (Hot) pressing becomes possible.
- thermoplastic used in all of these machine types, however, the processing of the thermoplastic used is carried out under the influence of temperatures which are relatively high for plastics.
- temperatures which are relatively high for plastics.
- care must be taken to ensure that the plastic to be processed takes this temperature into account - either since the coating, which was generally carried out in a vacuum, could no longer absorb moisture,
- plastic that has already been coated may have admixed with uncoated films or fibers (or also uncoated granules) for processing in the extruder.
- foils or foil packs which are coated on one or two sides, under certain circumstances may also be layered or packaged in multiple layers and may also contain uncoated (intermediate) foils,
- the active ingredient area per unit volume of plastic after further processing depends only on the number of layers of active ingredient per layer that has been achieved in the state after coating Thickness unit plastic, ie it only depends on the thickness of the films and whether they are coated on one or two sides.
- the thickness of the coating is only used to determine the active ingredient supply, i.e. the time how long the system remains in effect.
- the selected coating process and the parameters used here in particular also the parameters used within the coating process for the pretreatment of the surface (for example in the case of glowing or sputter etching), have large flows on whether a layer produced is only apparently (optically) or really tight against water vapor.
- uncoated intermediate films can be used. These uncoated intermediate foils must of course be included in the "layer coating per unit thickness plastic" balance.
- the chopped product would be with suitable feeding devices, e.g. "StopfSchnecken", quite well suited for loading processing machines.
- Films can be economically produced in large quantities in any width and, above all, in almost any required thickness. The latter possibility gives a very wide variation possibility for the content of active substance area per unit volume, which ultimately determines the effectiveness of the finished plastic.
- the use of foils as a raw material should always be considered when the average size is large Active substance areas per unit volume of plastic are to be generated. The difficulties of further processing are limited, given a correspondingly large production.
- the plastic containing 2 active ingredients initially preferably receives ions of the less noble element on the surface before a final state gradually stabilizes
- Granules can be economically produced in large quantities, but only in a very limited diameter range.
- the ratio of surface area to volume is defined strictly (linearly) as a function of the granule diameter. This property results in a very small variation possibility for the content of active substance area per unit volume, which ultimately determines the effectiveness of the finished plastic.
- the technology for coating bulk material for example electrical resistances
- the method according to the invention does not depend on a very uniform coating
- its use as a raw material should always be considered when small active substance areas per unit volume of plastic are sufficient.
- the desired ratio of the different active ingredients can be set by the ratio of the proportion of each of the two active ingredient components of the coating.
- the ratio of the release of ions of these two active substances does not remain stable during the period of use.
- Fibers can be produced economically in large quantities.
- the desired ratio of the active substance concentrations can be set by the ratio of the proportion of each of the two active substance components in the coating.
- the desired area of each active ingredient in the plastic volume unit and thus also the area ratio of the two active ingredients to one another can be set by the number of the respective coating processes with the subsequent spinning.
- Tapes are a special form of film. These can be economically produced in large quantities in any width and thickness required. The latter possibility is a very wide variation possibility for the active substance content area per unit volume, which ultimately determines the effective ⁇ ness of the finished plastic.
- tapes In view of the low manufacturing costs per unit of weight and the relatively low outlay for the two-part Coating of tapes, in which the highly automated technology which has been developed in the case of foils can be used, the use of tapes as a raw material must always be considered when an average large active ingredient area per unit volume of plastic is to be produced. Tapes can also be coated sufficiently on the narrow sides so that they can subsequently be considered coated all around.
- tapes can be drawn directly into many extrusion machines without further comminution (and the subsequent intermediate steps that normally follow), which results in a decisive simplification of the entire manufacturing process for plastics according to the invention, which, of course, involves an increased use of active ingredient must be bought.
- the two-sided coating of the film with only one active substance makes it possible to save drying again before further processing or final processing in the case of a water vapor-tight coating, but in the course of this further or final processing leads to a loss of active active ingredient area in the final product , because it inevitably directly presses active substance surfaces together.
- Another embodiment is characterized in that a coated plastic blank is first produced by one of the processes described above, but with a higher concentration of one or more antimicrobially active metal (s) and / or metal compound (s); this coated plastic blank is then comminuted and / or melted together with uncoated plastic blanks and finally brought into the desired shape by a conventional method.
- the same and / or different plastic (s) can be used for the uncoated plastic blanks than for the coated plastic blank. example
- test specimens were found to be fully effective against the colonization with the Staphylococcus epidermidis bacterium. This investigation was carried out according to the method described in DE-C-42 26 810.
- the plastic samples used are melt by hand by a ⁇ and stirring was manufactured ratios under controlled Temperaturver ⁇ .
- thermoplastic polyurethane films "Platilon U 073" (polyether type) 0.18 mm thick, which were used in a system that was actually intended for coating optical parts
- Silver 10 nm on one side b) Silver 30 nm on one side, c) Silver 60 nm on one side, d) Silver 30 nm on both sides, e) Silver 30 nm on one side and silver 60 nm on the other side f) Silver 30 nm on one side and copper 30 nm on the other side g) copper 30 nm double-sided,
- test plates a) and c) were produced in duplicate for control purposes.
- Staphylococcus epidermidis 5 x 10 germs / ml
- Staphylococcus aureus 5 x 10 germs / ml
- Streptococcus faecalis 5 x 10 germs / ml
- Escherichia coli 5 x 10 germs / ml
- Pseudomonas aeruginosa 5 x 10 germs / ml
- Candida albicans 5 x 10 germs / ml
- the plates were removed from the incubator and the wells were filled up again with physiological saline solution. After a further 15 minutes, the newly formed suspension was removed and placed in nutrient broth.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Dentistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Laminated Bodies (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4403016 | 1994-02-01 | ||
DE4403016A DE4403016A1 (de) | 1994-02-01 | 1994-02-01 | Bakterizide/fungizide Kunststoffkörper |
DE4427829 | 1994-08-05 | ||
DE4427829 | 1994-08-05 | ||
PCT/DE1995/000122 WO1995020878A1 (fr) | 1994-02-01 | 1995-02-01 | Procede de fabrication de corps plastiques bactericides/fongicides |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0711113A1 true EP0711113A1 (fr) | 1996-05-15 |
EP0711113B1 EP0711113B1 (fr) | 1997-07-23 |
Family
ID=25933460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95906894A Expired - Lifetime EP0711113B1 (fr) | 1994-02-01 | 1995-02-01 | Procede de fabrication de corps plastiques bactericides/fongicides |
Country Status (8)
Country | Link |
---|---|
US (2) | US5976562A (fr) |
EP (1) | EP0711113B1 (fr) |
AT (1) | ATE155649T1 (fr) |
CA (1) | CA2182390C (fr) |
DE (1) | DE59500419D1 (fr) |
DK (1) | DK0711113T3 (fr) |
ES (1) | ES2107913T3 (fr) |
WO (1) | WO1995020878A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2108388A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Dispersions aqueuses non-ioniques contenant de l'argent |
EP2108389A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane antimicrobien |
EP2108385A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Solution de polyuréthane-urée contenant de l'argent |
EP2108383A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane-urée antimicrobien |
DE102005053295C5 (de) * | 2005-11-08 | 2013-03-07 | Spiegelberg GmbH & Co. KG | Verfahren zur Herstellung eines steril verpackten, metallhaltigen Kunststoffkörpers mit antimikrobiell wirkender Oberfläche |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19758598B4 (de) * | 1997-11-20 | 2005-09-01 | Bechert, Thorsten, Dr. | Verfahren zur Prüfung von Materialien hinsichtlich ihrer potentiellen antimikrobiellen Wirksamkeit und der Proliferation von Zellen auf ihrer Oberfläche |
US6596401B1 (en) | 1998-11-10 | 2003-07-22 | C. R. Bard Inc. | Silane copolymer compositions containing active agents |
EP1066825A1 (fr) * | 1999-06-17 | 2001-01-10 | The Procter & Gamble Company | Produit antimicrobien pour les soins du corps |
US7547302B2 (en) * | 1999-07-19 | 2009-06-16 | I-Flow Corporation | Anti-microbial catheter |
US6350253B1 (en) | 1999-07-19 | 2002-02-26 | I-Flow Corporation | Catheter for uniform delivery of medication |
DE19936059A1 (de) * | 1999-07-30 | 2001-02-01 | J Peter Guggenbichler | Verfahren zur Herstellung von antimikrobiellen Kunststoffkörpern |
EP1457516A1 (fr) † | 1999-07-30 | 2004-09-15 | J. Peter Guggenbichler | Procédé de fabrication de corps en plastique anti-microbiens à comportement amélioré sur la durée |
US7179849B2 (en) | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
US6579539B2 (en) | 1999-12-22 | 2003-06-17 | C. R. Bard, Inc. | Dual mode antimicrobial compositions |
DE10043151A1 (de) * | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
US20020187175A1 (en) * | 2001-05-08 | 2002-12-12 | Petrea Randy D. | Antimicrobial polyurethane films |
DE10145275A1 (de) * | 2001-09-14 | 2003-04-03 | Coronet Werke Gmbh | Monofil mit antimikrobiellen Eigenschaften, Verwendung solcher Monofile als Borstenmaterial und Bürste oder Pinsel mit diesem Borstenmaterial |
DE10146050B4 (de) | 2001-09-18 | 2007-11-29 | Bio-Gate Ag | Verfahren zur Herstellung eines antimikrobiellen Kleb- und Beschichtungsstoffes |
AU2002357050A1 (en) | 2001-12-03 | 2003-06-17 | C.R. Bard, Inc. | Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same |
US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
ES2297196T3 (es) * | 2002-09-10 | 2008-05-01 | Prof. Dr. Josef-Peter Guggenbichler, Dr. Christoph Cichos Gbr Antimicrobial Argentum Technologies | Procedimiento para producir un producto antimicrobiano de material sintetico. |
BR0317876A (pt) * | 2002-12-31 | 2005-12-06 | Nicholas V Perricone | Composições de liberação de droga tópica estáveis |
US20040220534A1 (en) * | 2003-04-29 | 2004-11-04 | Martens Paul W. | Medical device with antimicrobial layer |
DE10340277B4 (de) * | 2003-08-29 | 2006-11-23 | Bio-Gate Bioinnovative Materials Gmbh | Körperpflegemittel mit Silber-Agglomeraten |
US20050246849A1 (en) * | 2004-05-10 | 2005-11-10 | Minkler Douglas J | Sanitizing handle for cleaning tool |
JP2008529711A (ja) * | 2005-02-19 | 2008-08-07 | ヤン、ウォン−ドン | 抗菌及び無痛機能を有する医療用針 |
US20060207403A1 (en) * | 2005-03-18 | 2006-09-21 | Dennis Moss | Bagel sandwich knife |
US20080127497A1 (en) * | 2005-10-31 | 2008-06-05 | Dennis Moss | Blade assembly |
US8631583B2 (en) | 2005-10-31 | 2014-01-21 | Dennis Moss | Bagel slicer |
DE502007006863D1 (de) * | 2006-02-20 | 2011-05-19 | Rehau Ag & Co | Profilleiste mit oligodynamisch wirkendem Material |
DE102006022236A1 (de) * | 2006-02-20 | 2007-08-30 | Rehau Ag + Co | Profilleiste |
WO2008138153A1 (fr) * | 2007-05-11 | 2008-11-20 | Brunnergässli Holding Ag | Composant d'une machine servant au traitement de produits alimentaires |
DE102007035063A1 (de) | 2007-07-26 | 2009-01-29 | Spiegelberg (Gmbh & Co.) Kg | Verfahren zur Herstellung eines antimikrobiellen Kunststoffproduktes |
EP2058379A1 (fr) | 2007-11-09 | 2009-05-13 | ACTEGA DS GmbH | Procédé de fabrication d'une fermeture de récipient |
CA2830298C (fr) | 2011-03-17 | 2016-08-16 | Transdermal Biotechnology, Inc. | Produits d'oxyde nitrique topiques comprenant de la lecithine et leurs methodes d'utilisation |
DE102011102636B3 (de) | 2011-05-27 | 2012-11-22 | Spiegelberg GmbH & Co. KG | Verfahren zur Herstellung eines antimikrobiellen Kunststoffproduktes |
DE102011102635B4 (de) | 2011-05-27 | 2014-02-13 | Spiegelberg GmbH & Co. KG | Verfahren zur Herstellung eines antimikrobiellen Kunststoffproduktes unter Verwendung eines Reduktons |
DE102011107637A1 (de) | 2011-07-18 | 2013-01-24 | Neschen Ag | Inzisionsfolie und Verfahren zu deren Herstellung |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
CA2926945A1 (fr) | 2013-06-25 | 2014-12-31 | Ricardo Benavides Perez | Additif bacteriostatique et fongistatique en melange maitre pour une application sur des plastiques et procede d'obtention de celui-ci |
US9883759B2 (en) | 2014-01-09 | 2018-02-06 | Goverre, Inc. | Closeable beverage lid |
WO2016160983A1 (fr) | 2015-03-30 | 2016-10-06 | C. R. Bard, Inc. | Application d'agents antimicrobiens sur des dispositifs médicaux |
DE102017121439A1 (de) | 2017-09-15 | 2019-03-21 | Hecosol Gmbh | Anti-mikrobielle Beschichtung |
DE102019108327A1 (de) * | 2019-03-29 | 2020-10-01 | Karl Leibinger Medizintechnik Gmbh & Co. Kg | Implantat mit intrinsischer antimikrobieller Wirksamkeit und Verfahren zu dessen Herstellung |
EP3907261A1 (fr) | 2020-05-06 | 2021-11-10 | Hecosol GmbH | Utilisation de revêtement antimicrobien |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3837125A1 (de) * | 1988-11-02 | 1990-05-03 | Signode System Gmbh | Verfahren zur herstellung von formkoerpern aus metall und einem thermoplastischen kunststoff |
US5236649A (en) * | 1988-12-23 | 1993-08-17 | The Dow Chemical | Extrudable thermoplastic particulates |
US5418056A (en) * | 1989-11-24 | 1995-05-23 | Mitsuboshi Belting Ltd. | Polymer composite with dispersed fine grains and a method for manufacturing the same |
DE3942112A1 (de) * | 1989-12-20 | 1991-06-27 | Braun Melsungen Ag | Medizinische vorrichtung mit einem oligodynamisch wirkenden material |
US5180585A (en) * | 1991-08-09 | 1993-01-19 | E. I. Du Pont De Nemours And Company | Antimicrobial compositions, process for preparing the same and use |
US5681575A (en) * | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
US5312685A (en) * | 1992-07-06 | 1994-05-17 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Atomic oxygen protective coating with resistance to undercutting at defect sites |
-
1995
- 1995-02-01 EP EP95906894A patent/EP0711113B1/fr not_active Expired - Lifetime
- 1995-02-01 AT AT95906894T patent/ATE155649T1/de active
- 1995-02-01 ES ES95906894T patent/ES2107913T3/es not_active Expired - Lifetime
- 1995-02-01 DE DE59500419T patent/DE59500419D1/de not_active Expired - Lifetime
- 1995-02-01 US US08/663,161 patent/US5976562A/en not_active Expired - Lifetime
- 1995-02-01 WO PCT/DE1995/000122 patent/WO1995020878A1/fr active IP Right Grant
- 1995-02-01 CA CA002182390A patent/CA2182390C/fr not_active Expired - Lifetime
- 1995-02-01 DK DK95906894.1T patent/DK0711113T3/da active
-
1999
- 1999-11-01 US US09/431,199 patent/US6544536B1/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO9520878A1 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005053295C5 (de) * | 2005-11-08 | 2013-03-07 | Spiegelberg GmbH & Co. KG | Verfahren zur Herstellung eines steril verpackten, metallhaltigen Kunststoffkörpers mit antimikrobiell wirkender Oberfläche |
EP2108388A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Dispersions aqueuses non-ioniques contenant de l'argent |
EP2108389A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane antimicrobien |
EP2108386A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane antimicrobien |
EP2108385A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Solution de polyuréthane-urée contenant de l'argent |
EP2108383A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane-urée antimicrobien |
EP2108384A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Appareils médicaux dotés d'un revêtement de polyuréthane-urée antimicrobien |
EP2108387A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Dispersions de polyuréthane aqueuses non ioniques contenant de l'argent |
EP2108382A1 (fr) | 2008-04-08 | 2009-10-14 | Bayer MaterialScience AG | Solution de polyuréthane-urée contenant de l'argent |
Also Published As
Publication number | Publication date |
---|---|
DE59500419D1 (de) | 1997-08-28 |
US5976562A (en) | 1999-11-02 |
CA2182390A1 (fr) | 1995-08-10 |
DK0711113T3 (da) | 1997-09-22 |
ES2107913T3 (es) | 1997-12-01 |
CA2182390C (fr) | 2006-12-19 |
EP0711113B1 (fr) | 1997-07-23 |
WO1995020878A1 (fr) | 1995-08-10 |
US6544536B1 (en) | 2003-04-08 |
ATE155649T1 (de) | 1997-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0711113B1 (fr) | Procede de fabrication de corps plastiques bactericides/fongicides | |
EP1427453B1 (fr) | Materiau d'adhesion et de revetement antimicrobien et son procede de production | |
EP1691606B1 (fr) | Matiere de revetement antimicrobienne | |
EP2091333B1 (fr) | Substance à action antimicrobienne | |
EP2278875B1 (fr) | Matériau stratifié | |
EP2176329B1 (fr) | Produits antimicrobiens en matière plastique et leur procédé de réalisation | |
EP2515660B1 (fr) | Formulations avec des nanoparticules d'argent | |
EP1755569B1 (fr) | Pansement | |
WO2010115587A1 (fr) | Procédé de fabrication d'un objet tridimensionnel au moyen d'une poudre plastique présentant des propriétés antimicrobiennes et poudre plastique présentant des propriétés antimicrobiennes destinée à un tel procédé | |
DE10120802A1 (de) | Verfahren zur Herstellung von gecoateten Nanopartikeln | |
CA2785505A1 (fr) | Nanoparticules a proprietes fongicides, procede d'elaboration correspondant, et utilisation de celles-ci dans la fabrication de differents articles | |
DE4403016A1 (de) | Bakterizide/fungizide Kunststoffkörper | |
EP1210386B2 (fr) | Procede de fabrication de corps en plastique anti-microbiens a comportement ameliore sur la duree | |
EP2217296B1 (fr) | Matériau de suture chirurgical | |
EP2654429A1 (fr) | Procédé de fabrication d'une dispersion contenant des nanoparticules d'argent ainsi qu'utilisation d'un mélange contenant des nanoparticules d'argent en tant qu'agent de revêtement | |
EP1852497A1 (fr) | Couche antimicrobienne et son utilisation | |
EP1611272B1 (fr) | Corps façonnes cellulosiques a action fonctionnelle et leur procede de fabrication | |
EP2813247A1 (fr) | Polymère équipé d'antimicrobien avec particules intégrées et élément de désinfection à base de ce polymère | |
EP3946487A1 (fr) | Implant doté d'une efficacité antimicrobienne intrinsèque et procédé de sa production | |
KR20080042637A (ko) | 새로운 은(銀)나노 백탄조성물을 이용한 기능성 마스터베치제조 방법 | |
WO2021185896A1 (fr) | Matériaux composites antimicrobiens améliorés contenant du tungstène | |
DE102016206007A1 (de) | Wundauflage und Verfahren zu deren antibakterieller Funktionalisierung | |
WO2007124800A1 (fr) | Linge à effet antimicrobien et utilisation de ce linge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19951205 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 19960704 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 155649 Country of ref document: AT Date of ref document: 19970815 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19970805 |
|
REF | Corresponds to: |
Ref document number: 59500419 Country of ref document: DE Date of ref document: 19970828 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. PATENTANWAELTE |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2107913 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: KRALL, THEODOR Free format text: KRALL, THEODOR#ROSENAU 7A#A-6600 LECHASCHAU (AT) $ GUGGENBICHLER, J. PETER#OBERER STEPHANSBERG 42A#D-96049 BAMBERG (DE) -TRANSFER TO- KRALL, THEODOR#ROSENAU 7A#A-6600 LECHASCHAU (AT) $ GUGGENBICHLER, J. PETER#OBERER STEPHANSBERG 42A#D-96049 BAMBERG (DE) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20140325 Year of fee payment: 20 Ref country code: DK Payment date: 20140221 Year of fee payment: 20 Ref country code: CH Payment date: 20140220 Year of fee payment: 20 Ref country code: NL Payment date: 20140220 Year of fee payment: 20 Ref country code: SE Payment date: 20140220 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20140220 Year of fee payment: 20 Ref country code: IT Payment date: 20140225 Year of fee payment: 20 Ref country code: BE Payment date: 20140219 Year of fee payment: 20 Ref country code: AT Payment date: 20140219 Year of fee payment: 20 Ref country code: FR Payment date: 20140218 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20140220 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 59500419 Country of ref document: DE Representative=s name: HOFSTETTER, SCHURACK & PARTNER PATENT- UND REC, DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 59500419 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 59500419 Country of ref document: DE Ref country code: DK Ref legal event code: EUP Effective date: 20150201 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V4 Effective date: 20150201 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20150131 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 155649 Country of ref document: AT Kind code of ref document: T Effective date: 20150201 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20150424 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150202 |